F.D.A. Advisers Meet on Covid Shots by Novavax
A federal advisory committee on Tuesday will vote on whether regulators should authorize a Covid-19 vaccine made by Novavax, an early beneficiary of the government’s Operation Warp Speed program. The experts to the Food and Drug Administration (whose meeting you can watch here) will base their recommendation on the company’s clinical trial data, which is…